drugset / Trial / NCT04808466

Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy

NCT04808466

RandomizedParallel-groupSingle-blindTreatment

Summary

This study is a prospective, randomized, comparative clinical trial conducted by Wuhan Union Hospital and aim to compare the therapeutic effects of Lobaplatin and Paclitaxel in advanced gastric cancer patients with D2 surgery combined with hyperthermic intraperitoneal chemotherapy

Timeline

Start
2021-09-18
Primary completion
2022-09-01
Completion
2025-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lobaplatin Small molecule 50 mg/m2 Other
Subject Paclitaxel Small molecule 75 mg/m2 Other